SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

CareDx, Inc. – ‘10-K’ for 12/31/19 – ‘EX-23.1’

On:  Thursday, 2/27/20, at 5:36pm ET   ·   As of:  2/28/20   ·   For:  12/31/19   ·   Accession #:  1217234-20-33   ·   File #:  1-36536

Previous ‘10-K’:  ‘10-K’ on 3/6/19 for 12/31/18   ·   Next:  ‘10-K’ on 2/24/21 for 12/31/20   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/28/20  CareDx, Inc.                      10-K       12/31/19  102:13M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.71M 
 2: EX-4.9      Instrument Defining the Rights of Security Holders  HTML     54K 
 3: EX-10.10    Material Contract                                   HTML     39K 
 4: EX-21.1     Subsidiaries List                                   HTML     32K 
 5: EX-23.1     Consent of Experts or Counsel                       HTML     31K 
 6: EX-23.2     Consent of Experts or Counsel                       HTML     33K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     36K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     36K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     34K 
92: R1          Document and Entity Information                     HTML     63K 
40: R2          Consolidated Balance Sheets                         HTML    116K 
28: R3          Consolidated Balance Sheets (Parenthetical)         HTML     49K 
59: R4          Consolidated Statements of Operations               HTML    114K 
94: R5          Consolidated Statements of Comprehensive Loss       HTML     52K 
41: R6          Consolidated Statements of Convertible Preferred    HTML    134K 
                Stock and Stockholders' Equity                                   
29: R7          Consolidated Statements of Convertible Preferred    HTML     32K 
                Stock and Stockholders' Equity (Parenthetical)                   
62: R8          Consolidated Statements of Cash Flows               HTML    172K 
91: R9          Organization and Description of Business            HTML     44K 
48: R10         Summary of Significant Accounting Policies          HTML     99K 
34: R11         Net Loss Per Share Attributable to CareDx, Inc      HTML     79K 
67: R12         Fair Value Measurements                             HTML    147K 
99: R13         Business Combinations                               HTML     64K 
47: R14         Goodwill and Intangible Assets                      HTML    149K 
33: R15         Balance Sheet Components                            HTML     81K 
66: R16         Commitments and Contingencies                       HTML     66K 
98: R17         Debt                                                HTML     36K 
49: R18         Stockholders' Equity                                HTML     37K 
32: R19         Plan 401(K)                                         HTML     32K 
73: R20         Warrants                                            HTML     45K 
80: R21         Stock Incentive Plans                               HTML    152K 
51: R22         Income Taxes                                        HTML    160K 
16: R23         Segment Reporting                                   HTML     93K 
72: R24         Subsequent Events                                   HTML     33K 
79: R25         Selected Quarterly Financial Data (Unaudited)       HTML     86K 
50: R26         Summary of Significant Accounting Policies          HTML    166K 
                (Policies)                                                       
15: R27         Net Loss Per Share Attributable to CareDx, Inc      HTML     78K 
                (Tables)                                                         
71: R28         Fair Value Measurements (Tables)                    HTML    144K 
82: R29         Business Combinations (Tables)                      HTML     57K 
101: R30         Goodwill and Intangible Assets (Tables)             HTML    143K  
68: R31         Balance Sheet Components (Tables)                   HTML     85K 
30: R32         Commitments and Contingencies (Tables)              HTML     52K 
44: R33         Warrants (Tables)                                   HTML     48K 
102: R34         Stock Incentive Plans (Tables)                      HTML    143K  
69: R35         Income Taxes (Tables)                               HTML    163K 
31: R36         Segment Reporting (Tables)                          HTML     95K 
45: R37         Selected Quarterly Financial Data (Unaudited)       HTML     85K 
                (Tables)                                                         
100: R38         Organization and Description of Business -          HTML     51K  
                Additional Information (Detail)                                  
70: R39         Summary of Significant Accounting Policies -        HTML     84K 
                Additional Information (Detail)                                  
84: R40         Net Loss Per Share Attributable to CareDx, Inc -    HTML     62K 
                Computation of Basic and Diluted Net Loss Per                    
                Share (Detail)                                                   
74: R41         Net Loss Per Share Attributable to CareDx, Inc -    HTML     47K 
                Potentially Dilutive Securities Excluded from                    
                Diluted Net Loss Per Share (Detail)                              
20: R42         Net Loss Per Share Attributable to CareDx, Inc -    HTML     52K 
                Additional Information (Detail)                                  
56: R43         Fair Value Measurements - Fair Value of Financial   HTML     45K 
                Assets and Liabilities Measured on Recurring Basis               
                (Detail)                                                         
85: R44         Fair Value Measurements - Additional Information    HTML     31K 
                (Details)                                                        
75: R45         Fair Value Measurements - Summary of Issuances,     HTML     68K 
                Changes in Fair Value and Classifications of Level               
                3 Financial Instruments (Detail)                                 
21: R46         Fair Value Measurements - Summary of Common Stock   HTML     47K 
                Warrant and Derivative Liability Valuation                       
                Assumptions (Detail)                                             
57: R47         Business Combinations - Additional Information      HTML     96K 
                (Detail)                                                         
83: R48         Business Combinations - Summary of Consideration    HTML     61K 
                Paid and Provisional Amounts of Assets Acquired                  
                and Liabilities Assumed Recognized at Their                      
                Estimated Fair Value (Detail)                                    
76: R49         Business Combinations - Summary of Identified       HTML     42K 
                Intangible Assets Acquired at Acquisition Date                   
                (Detail)                                                         
61: R50         Goodwill and Intangible Assets - Summary of         HTML     35K 
                Goodwill (Detail)                                                
90: R51         Goodwill and Intangible Assets - Additional         HTML     85K 
                Information (Detail)                                             
43: R52         Goodwill and Intangible Assets - Summary of         HTML     68K 
                Intangible Assets (Detail)                                       
27: R53         Goodwill and Intangible Assets - Summary of Fair    HTML     50K 
                Values of Assets Acquired and Liabilities Assumed                
                as of Acquisition Date (Detail)                                  
60: R54         Goodwill and Intangible Assets - Summary of         HTML     55K 
                Estimated Future Amortization Expense of                         
                Intangible Assets (Detail)                                       
89: R55         Balance Sheet Components - Summary of Inventory     HTML     40K 
                (Detail)                                                         
42: R56         Balance Sheet Components - Components of Property   HTML     47K 
                and Equipment (Detail)                                           
26: R57         Balance Sheet Components - Additional Information   HTML     39K 
                (Detail)                                                         
58: R58         Balance Sheet Components - Components of Accrued    HTML     55K 
                Expenses and Other Current Liabilities (Detail)                  
93: R59         Commitment and Contingencies - Lease Cost           HTML     46K 
                (Details)                                                        
54: R60         Commitment and Contingencies - Schedule of Future   HTML     48K 
                Minimum Lease Commitments Under Operating And                    
                Finance Leases (Details)                                         
19: R61         Commitments and Contingencies - Additional          HTML     47K 
                Information (Detail)                                             
78: R62         Debt - Additional Information (Detail)              HTML     67K 
88: R63         Stockholders' Equity - Additional Information       HTML     74K 
                (Detail)                                                         
52: R64         Plan 401(K) - Additional Information (Detail)       HTML     32K 
18: R65         Warrants - Additional Information (Details)         HTML     38K 
77: R66         Warrants - Outstanding Warrants To Purchase Common  HTML     44K 
                Stock Warrants (Detail)                                          
87: R67         Stock Incentive Plans - Additional Information      HTML    120K 
                (Detail)                                                         
55: R68         Stock Incentive Plans - Summary of Options, RSUs    HTML     95K 
                Activity under 2014 Equity Incentive Plan and 2016               
                Inducement Plan and Related Information (Detail)                 
17: R69         Stock Incentive Plans - Summary of Options          HTML     52K 
                Outstanding Vested and Expected to Vest (Detail)                 
22: R70         Stock Incentive Plans - Weighted-Average            HTML     55K 
                Assumptions Used to Estimated Fair Value of                      
                Share-Based Awards (Detail)                                      
36: R71         Stock Incentive Plans - Summary of Expense          HTML     44K 
                Relating to Employee and Nonemployee Stock-Based                 
                Payment Awards from Stock Options and RSUs                       
                (Detail)                                                         
95: R72         Income Taxes - Summary of Loss Before Income Taxes  HTML     39K 
                (Detail)                                                         
64: R73         Income Taxes - Components of Provision for          HTML     61K 
                (Benefit from) Income Taxes (Detail)                             
24: R74         Income Taxes - Schedule of Provision for Tax        HTML     63K 
                Differed from Amounts Computed by Applying U.S.                  
                Federal Income Tax Rate to Loss Before Income                    
                (Detail)                                                         
39: R75         Income Taxes - Schedule of Deferred Income Tax      HTML     70K 
                Assets and Liabilities (Detail)                                  
97: R76         Income Taxes - Additional Information (Detail)      HTML     62K 
65: R77         Income Taxes - Schedule of Reconciliation of        HTML     38K 
                Unrecognized Tax Benefits (Detail)                               
25: R78         Segment Reporting - Additional Information          HTML     33K 
                (Detail)                                                         
35: R79         Segment Reporting - Reportable Revenues by          HTML     70K 
                Geographic Regions (Detail)                                      
23: R80         Segment Reporting - Long-Lived Assets Consisting    HTML     40K 
                of Property and Equipment, Net by Geographic                     
                Regions (Detail)                                                 
37: R81         Subsequent Events (Details)                         HTML     39K 
96: R82         Selected Quarterly Financial Data (Unaudited) -     HTML     60K 
                Summary of Selected Quarterly Financial Data                     
                (Detail)                                                         
63: R9999       Uncategorized Items - cdna-20191231.htm             HTML     32K 
81: XML         IDEA XML File -- Filing Summary                      XML    185K 
38: XML         XBRL Instance -- cdna-20191231_htm                   XML   3.34M 
46: EXCEL       IDEA Workbook of Financial Reports                  XLSX    121K 
11: EX-101.CAL  XBRL Calculations -- cdna-20191231_cal               XML    332K 
12: EX-101.DEF  XBRL Definitions -- cdna-20191231_def                XML    982K 
13: EX-101.LAB  XBRL Labels -- cdna-20191231_lab                     XML   2.26M 
14: EX-101.PRE  XBRL Presentations -- cdna-20191231_pre              XML   1.34M 
10: EX-101.SCH  XBRL Schema -- cdna-20191231                         XSD    244K 
86: JSON        XBRL Instance as JSON Data -- MetaLinks              454±   728K 
53: ZIP         XBRL Zipped Folder -- 0001217234-20-000033-xbrl      Zip    601K 


‘EX-23.1’   —   Consent of Experts or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

                  EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements on Form S-3 Nos. 333-211700 and 333-227168, on Form S-1 Nos. 333-217461 and 333-220183 and on Form S-8 Nos. 333-197493, 333-203128, 333-211538, 333-217462, 333-225991, 333-231523, and 333-233710, of our reports dated February 27, 2020, relating to the consolidated financial statements of CareDx, Inc. and its subsidiaries (the “Company”) , (which expresses an unqualified opinion and includes an explanatory paragraph related to the Company’s change in method of accounting for leases in fiscal year 2019 due to the adoption of ASC 842, Leases), and the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2019.

/s/ Deloitte & Touche LLP
San Jose, California
February 27, 2020






Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed as of:2/28/20
Filed on:2/27/204,  8-K
For Period end:12/31/19DEF 14A
 List all Filings 


7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/27/23  CareDx, Inc.                      10-K       12/31/22  101:12M
 4/15/22  CareDx, Inc.                      424B5       4/14/22    2:311K                                   Donnelley … Solutions/FA
 2/24/22  CareDx, Inc.                      10-K       12/31/21   97:11M
 1/21/21  CareDx, Inc.                      424B5                  1:511K                                   Donnelley … Solutions/FA
 1/19/21  CareDx, Inc.                      424B5                  1:507K                                   Donnelley … Solutions/FA
 9/01/20  SEC                               UPLOAD9/30/20    2:39K  CareDx, Inc.
 8/05/20  SEC                               UPLOAD9/30/20    2:43K  CareDx, Inc.
Top
Filing Submission 0001217234-20-000033   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 4, 5:25:59.1pm ET